{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:36:15Z","timestamp":1787027775962,"version":"build-2736575974"},"reference-count":141,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Whilst typically benign, a subset of meningiomas displays aggressive and recurrent behavior. There is a paucity of reliable treatment options for this subset of patients and a relative lack of consensus on how to best manage these patients. This clinical challenge reflects underlying molecular complexity, driven by NF2, TRAF7, and CDKN2A\/B mutations alongside pervasive epigenetic dysregulation. High-throughput molecular profiling studies have proposed biologically distinct meningioma subgroups with varying clinical trajectories and therapeutic vulnerabilities. Distinct cell lineages of meningeal precursors are now appreciated to be essential in the establishment of the meninges. The numerous cellular lineages involved in meningeal development, the heterogeneity of meningioma location and (epi)genomic behavior, and the variability in its clinical and radiological manifestations raise the question of what critical insights can be gained by understanding meningeal development during embryogenesis to understand meningioma tumorigenicity. The current paper examines this paradigm by highlighting spatially linked mechanisms of anaplasia and treatment resistance, including the role of neural crest-derived convexity meninges in promoting dedifferentiation via YAP\/TAZ signaling and mesoderm-derived skull base regions in maintaining TRAF7-mediated vulnerabilities. We further elucidate the emerging synthetic lethal paradigms, CRISPR-enabled target discovery, and PROTAC-mediated degradation strategies that may transform the therapeutic landscape of clinically challenging meningiomas driven by complex oncogenic circuitry. By bridging embryogenesis, spatial genomics, and molecular targeting, we propose a developmentally informed, lineage-stratified model for advancing precision therapeutics in high-grade and recurrent meningiomas.<\/jats:p>","DOI":"10.3390\/cancers17162694","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:59:01Z","timestamp":1755601141000},"page":"2694","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Spatially Encoded Oncogenesis and Transcriptional Plasticity in Meningioma: Drivers of Therapeutic Resistance and Opportunities for Targeted Intervention"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5835-5179","authenticated-orcid":false,"given":"Matthew A.","family":"Abikenari","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Regev","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7013-8150","authenticated-orcid":false,"given":"Brandon H.","family":"Bergsneider","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3906-5317","authenticated-orcid":false,"given":"Vratko","family":"Himic","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyas","family":"Annagiri","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily H.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Medikonda","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeeva","family":"Jeyaretna","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Oxford University Hospitals, University of Oxford, Oxford OX1 2JD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Fountain","sequence":"additional","affiliation":[{"name":"MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX1 2JD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jnen\/63.4.275","article-title":"Meningioma pathology, genetics, and biology","volume":"63","author":"Lamszus","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(04)16153-9","article-title":"Meningiomas","volume":"363","author":"Whittle","year":"2004","journal-title":"Lancet Lond. Engl."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J. Neurooncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3171\/2012.9.JNS12294","article-title":"Surgery for convexity meningioma: Simpson Grade I resection as the goal: Clinical article","volume":"117","author":"Hasseleid","year":"2012","journal-title":"J. Neurosurg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(06)70625-1","article-title":"Histological classification and molecular genetics of meningiomas","volume":"5","author":"Riemenschneider","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/neuonc\/nox101","article-title":"Diagnostic challenges in meningioma","volume":"19","author":"Nowosielski","year":"2017","journal-title":"Neuro-Oncology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3171\/jns.1985.62.1.0018","article-title":"Meningioma: Analysis of recurrence and progression following neurosurgical resection","volume":"62","author":"Mirimanoff","year":"1985","journal-title":"J. Neurosurg."},{"key":"ref_8","unstructured":"Alruwaili, A.A., and De Jesus, O. (2025). Meningioma. StatPearls, StatPearls Publishing. Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560538\/."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11060-010-0348-9","article-title":"A review of malignant meningiomas: Diagnosis, characteristics, and treatment","volume":"99","author":"Hanft","year":"2010","journal-title":"J. Neurooncol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1515\/med-2016-0032","article-title":"Meningioma recurrence","volume":"11","author":"Bencze","year":"2016","journal-title":"Open Med. Wars. Pol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","article-title":"A clinically applicable integrative molecular classification of meningiomas","volume":"597","author":"Nassiri","year":"2021","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1586\/ern.11.38","article-title":"Medical treatment of recurrent meningiomas","volume":"11","author":"Chamberlain","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e23288","DOI":"10.1002\/dvg.23288","article-title":"Developmental biology of the meninges","volume":"57","author":"Dasgupta","year":"2019","journal-title":"Genesis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2007-1016956","article-title":"Recurrence and Outcome in Skull Base Meningiomas: Do They Differ from Other Intracranial Meningiomas?","volume":"18","author":"Nanda","year":"2008","journal-title":"Skull Base"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2010.07.001","article-title":"There\u2019s no place like home for a neural stem cell","volume":"7","author":"Siegenthaler","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1523\/JNEUROSCI.2575-06.2006","article-title":"Stromal-Derived Factor-1 (CXCL12) Regulates Laminar Position of Cajal-Retzius Cells in Normal and Dysplastic Brains","volume":"26","author":"Paredes","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/sj.leu.2404357","article-title":"The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis","volume":"20","author":"Ratajczak","year":"2006","journal-title":"Leukemia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-61779-510-7_11","article-title":"Convergent extension analysis in mouse whole embryo culture","volume":"839","author":"Pryor","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/neuonc\/noy178","article-title":"Molecular and translational advances in meningiomas","volume":"21","author":"Suppiah","year":"2019","journal-title":"Neuro-Oncology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e1440931","DOI":"10.1080\/2162402X.2018.1440931","article-title":"Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma","volume":"7","author":"Pinton","year":"2018","journal-title":"OncoImmunology"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lotsch, C., Warta, R., and Herold-Mende, C. (2024). The Molecular and Immunological Landscape of Meningiomas. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179631"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Medikonda, R., Abikenari, M., Schonfeld, E., and Lim, M. (2025). The Metabolic Orchestration of Immune Evasion in Glioblastoma: From Molecular Perspectives to Therapeutic Vulnerabilities. Cancers, 17.","DOI":"10.3390\/cancers17111881"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Yu, D., Wang, J., Hu, L., Wu, Y., Wang, T., Li, Z., Wang, Z., Ding, Q., Sun, Y., and Li, Z. (2025). Knowledge structures and research hotspots of immunotherapy for brain metastasis, glioma, meningioma, and pituitary adenoma: A bibliometric and visualization review. Chin. Chem. Lett., 110995.","DOI":"10.1016\/j.cclet.2025.110995"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/glioma.glioma_4_24","article-title":"Revisiting glioblastoma classification through an immunological lens: A narrative review","volume":"7","author":"Abikenari","year":"2024","journal-title":"Glioma"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ramapriyan, R., Barker, F.G., Richardson, L.G., Sun, J., Vandecandelaere, G., Shim, J.M., De Vlaminck, G., Gaffey, M., Grewal, E.P., and Tazhibi, M. (2025). Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells. Neuro-Oncology.","DOI":"10.1093\/neuonc\/noaf155"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e35935","DOI":"10.1002\/cncr.35935","article-title":"Top advances of the year: The status of chimeric antigen receptor T cells in Neuro-Oncology","volume":"131","author":"Medikonda","year":"2025","journal-title":"Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1097\/MS9.0000000000002491","article-title":"CAR-T-cell therapy in meningioma: Current investigations, advancements and insight into future directions","volume":"86","author":"Rath","year":"2024","journal-title":"Ann. Med. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Abikenari, M., Liu, J., Ha, J.H., Annagiri, S., Himic, V., Medikonda, R., Kim, L., Choi, J., and Lim, M. (2025). Emerging trends in cell-based therapies: Contemporary advances and ethical considerations in translational neurosurgical oncology. J. Neurooncol.","DOI":"10.1007\/s11060-025-05170-2"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","article-title":"EANO guidelines for the diagnosis and treatment of meningiomas","volume":"17","author":"Goldbrunner","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014\u20132018","volume":"23","author":"Ostrom","year":"2021","journal-title":"Neuro-Oncology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1158\/1078-0432.CCR-18-0641","article-title":"Phosphoproteomic and Kinomic Signature of Clinically Aggressive Grade I (1.5) Meningiomas Reveals RB1 Signaling as a Novel Mediator and Biomarker","volume":"26","author":"Parada","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Patel, B., Desai, R., Pugazenthi, S., Butt, O.H., Huang, J., and Kim, A.H. (2022). Identification and Management of Aggressive Meningiomas. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.851758"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"djv377","DOI":"10.1093\/jnci\/djv377","article-title":"TERT Promoter Mutations and Risk of Recurrence in Meningioma","volume":"108","author":"Sahm","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/neuonc\/noae170","article-title":"cIMPACT-NOW update 8, Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas","volume":"27","author":"Sahm","year":"2025","journal-title":"Neuro-Oncology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s00701-022-05301-y","article-title":"The WHO 2021 Classification of Central Nervous System tumours: A practical update on what neurosurgeons need to know-a minireview","volume":"164","author":"Torp","year":"2022","journal-title":"Acta Neurochir."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/ijc.22855","article-title":"Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas","volume":"121","author":"Ketter","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1586\/era.11.162","article-title":"Meningioma: Review of the literature with emphasis on the approach to radiotherapy","volume":"11","author":"Marta","year":"2011","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11910-013-0337-4","article-title":"Meningioma","volume":"13","author":"Fathi","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3171\/jns.2006.105.4.538","article-title":"Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience","volume":"105","author":"Yano","year":"2006","journal-title":"J. Neurosurg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3171\/2009.6.JNS081490","article-title":"Risk profile associated with convexity meningioma resection in the modern neurosurgical era","volume":"112","author":"Sanai","year":"2010","journal-title":"J Neurosurg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3171\/2009.8.JNS09695","article-title":"Long-term control of petroclival meningiomas through radiosurgery","volume":"112","author":"Flannery","year":"2010","journal-title":"J. Neurosurg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1083\/jcb.147.5.1109","article-title":"Perlecan maintains the integrity of cartilage and some basement membranes","volume":"147","author":"Costell","year":"1999","journal-title":"J. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41388-020-01568-6","article-title":"The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges","volume":"40","author":"Fountain","year":"2021","journal-title":"Oncogene"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2011.2.FOCUS1116","article-title":"The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments","volume":"30","author":"Choy","year":"2011","journal-title":"Neurosurg. Focus"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11910-020-01084-w","article-title":"A Practical Overview on the Molecular Biology of Meningioma","volume":"20","year":"2020","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/hmg\/9.10.1495","article-title":"Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas","volume":"9","author":"Gutmann","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/biof.5520280307","article-title":"Holistic and network analysis of meningioma pathogenesis and malignancy","volume":"28","author":"Tao","year":"2006","journal-title":"BioFactors Oxf. Engl."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885","article-title":"Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression","volume":"70","author":"Zhang","year":"2010","journal-title":"Cancer Res."},{"key":"ref_49","unstructured":"Alliance for Clinical Trials in Oncology (2025, May 03). Phase II Trial of SMO\/AKT\/NF2\/CDK Inhibitors in Progressive Meningiomas With SMO\/AKT\/NF2\/CDK Pathway Mutations. Clinical Trial Registration, NCT02523014, clinicaltrials.gov, Available online: https:\/\/clinicaltrials.gov\/study\/NCT02523014."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Wang, X., Gong, Y., Wang, D., Xie, Q., Zheng, M., Zhou, Y., Li, Q., Yang, Z., Tang, H., and Li, Y. (2012). Analysis of gene expression profiling in meningioma: Deregulated signaling pathways associated with meningioma and EGFL6 overexpression in benign meningioma tissue and serum. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0052707"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1158\/0008-5472.CAN-05-0240","article-title":"Meningioma transcript profiles reveal deregulated Notch signaling pathway","volume":"65","author":"Cuevas","year":"2005","journal-title":"Cancer Res."},{"key":"ref_52","first-page":"1000101","article-title":"Molecular Targets and Treatment of Meningioma","volume":"1","author":"Miller","year":"2014","journal-title":"J. Neurol. Neurosurg."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Abikenari, M.A. (2024). A Critical Appraisal of the Genotypic Features, Phenotypic Drivers and Therapeutic vulnerabilities in Recurrent Meningiomas. OSF Prepr.","DOI":"10.31219\/osf.io\/ckh2t"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Abikenari, M.A., Enayati, I., Fountain, D.M., and Leite, M.I. (2024). Navigating glioblastoma therapy: A narrative review of emerging immunotherapeutics and small-molecule inhibitors. Microbes Immun., 5075.","DOI":"10.36922\/mi.5075"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2016.81","article-title":"Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system","volume":"29","author":"Yuzawa","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Birzu, C., French, P., Caccese, M., Cerretti, G., Idbaih, A., Zagonel, V., and Lombardi, G. (2020). Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives. Cancers, 13.","DOI":"10.3390\/cancers13010047"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/annonc\/mdx763","article-title":"Progestin-associated shift of meningioma mutational landscape","volume":"29","author":"Peyre","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00701-020-04650-w","article-title":"Meningiomas from a developmental perspective: Exploring the crossroads between meningeal embryology and tumorigenesis","volume":"163","author":"Boetto","year":"2021","journal-title":"Acta Neurochir."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01406315","article-title":"Osteomatous meningioma report of two cases","volume":"60","author":"Giordano","year":"1982","journal-title":"Acta Neurochir."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-05-0043","article-title":"Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma","volume":"65","author":"Lusis","year":"2005","journal-title":"Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Okano, A., Miyawaki, S., Hongo, H., Dofuku, S., Teranishi, Y., Mitsui, J., Tanaka, M., Shin, M., Nakatomi, H., and Saito, N. (2021). Associations of pathological diagnosis and genetic abnormalities in meningiomas with the embryological origins of the meninges. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-86298-9"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00701-012-1611-y","article-title":"Malignant potential of skull base versus non-skull base meningiomas: Clinical series of 1,663 cases","volume":"155","author":"Cornelius","year":"2013","journal-title":"Acta Neurochir."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10143-018-1005-6","article-title":"Skull base versus non-skull base meningioma surgery in the elderly","volume":"42","author":"Meling","year":"2019","journal-title":"Neurosurg. Rev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3171\/jns.1999.90.5.0823","article-title":"Radiotherapy in the treatment of benign meningioma of the skull base","volume":"90","author":"Nutting","year":"1999","journal-title":"J. Neurosurg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3171\/2009.9.JNS09617","article-title":"A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas","volume":"112","author":"McGovern","year":"2010","journal-title":"J. Neurosurg."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1227\/01.NEU.0000310692.80289.28","article-title":"Surgery for convexity meningiomas","volume":"63","author":"Morokoff","year":"2008","journal-title":"Neurosurgery"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11060-025-05082-1","article-title":"The hormonal nexus in PIK3CA-mutated meningiomas: Implications for targeted therapy and clinical trial design","volume":"174","author":"Abikenari","year":"2025","journal-title":"J. Neurooncol"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1038\/s41467-024-46531-1","article-title":"Expected and unexpected effects after systemic inhibition of Hippo transcriptional output in cancer","volume":"15","author":"Baroja","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12032-025-02652-1","article-title":"Targeting EGFR and PI3K\/mTOR pathways in glioblastoma: Innovative therapeutic approaches","volume":"42","author":"Singh","year":"2025","journal-title":"Med. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/neuonc\/now029","article-title":"PIK3CA mutations in meningioma","volume":"18","author":"Zadeh","year":"2016","journal-title":"Neuro-Oncology"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Linsler, S., Kraemer, D., Driess, C., Oertel, J., Kammers, K., Rahnenf\u00fchrer, J., Ketter, R., and Urbschat, S. (2014). Molecular Biological Determinations of Meningioma Progression and Recurrence. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094987"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","article-title":"Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities","volume":"54","author":"Choudhury","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Shen, L., Lin, D., Cheng, L., Tu, S., Wu, H., Xu, W., Pan, Y., Wang, X., Zhang, J., and Shao, A. (2020). Is DNA Methylation a Ray of Sunshine in Predicting Meningioma Prognosis?. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01323"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: A multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00221652","article-title":"Morphogenesis of rat cranial meninges","volume":"257","author":"Angelov","year":"1989","journal-title":"Cell Tissue Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1469-7580.2008.00893.x","article-title":"Impaired meningeal development in association with apical expansion of calvarial bone osteogenesis in the Foxc1 mutant","volume":"212","author":"Vivatbutsiri","year":"2008","journal-title":"J. Anat."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.mod.2008.06.007","article-title":"Cell lineage in mammalian craniofacial mesenchyme","volume":"125","author":"Yoshida","year":"2008","journal-title":"Mech. Dev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0012-1606(73)90061-4","article-title":"A biological cell labeling technique and its use in expermental embryology","volume":"30","year":"1973","journal-title":"Dev. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-021-03874-9","article-title":"The integrated multiomic diagnosis of sporadic meningiomas: A review of its clinical implications","volume":"156","author":"Robert","year":"2022","journal-title":"J. Neurooncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0012-1606(87)90118-7","article-title":"Mapping of the early neural primordium in quail-chick chimeras. II. The prosencephalic neural plate and neural folds: Implications for the genesis of cephalic human congenital abnormalities","volume":"120","author":"Couly","year":"1987","journal-title":"Dev. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/dev.114.1.1","article-title":"The developmental fate of the cephalic mesoderm in quail-chick chimeras","volume":"114","author":"Couly","year":"1992","journal-title":"Development"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0092-8674(87)90664-7","article-title":"Expression of the proto-oncogene int-1 is restricted to specific neural cells in the developing mouse embryo","volume":"50","author":"Wilkinson","year":"1987","journal-title":"Cell"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1523\/JNEUROSCI.17-07-02376.1997","article-title":"Prostaglandin D synthase (beta-trace) in human arachnoid and meningioma cells: Roles as a cell marker or in cerebrospinal fluid absorption, tumorigenesis, and calcification process","volume":"17","author":"Yamashima","year":"1997","journal-title":"J. Neurosci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-12-804280-9.00006-8","article-title":"Molecular genetics of meningiomas","volume":"169","author":"Youngblood","year":"2020","journal-title":"Handb. Clin. Neurol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e60005","DOI":"10.7554\/eLife.60005","article-title":"An atlas of neural crest lineages along the posterior developing zebrafish at single-cell resolution","volume":"10","author":"Howard","year":"2021","journal-title":"eLife"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.devcel.2020.06.009","article-title":"Single-Cell Transcriptomic Analyses of the Developing Meninges Reveal Meningeal Fibroblast Diversity and Function","volume":"54","author":"DeSisto","year":"2020","journal-title":"Dev. Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"73","DOI":"10.21638\/11701\/spbu03.2017.203","article-title":"The development and origins of vertebrate meninges","volume":"62","author":"Batarfi","year":"2017","journal-title":"Biol. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13244-019-0697-7","article-title":"Dural masses: Meningiomas and their mimics","volume":"10","author":"Lyndon","year":"2019","journal-title":"Insights Imaging"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/1073858420954826","article-title":"Meninges: A Widespread Niche of Neural Progenitors for the Brain","volume":"27","author":"Decimo","year":"2021","journal-title":"Neuroscientist"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"dev200065","DOI":"10.1242\/dev.200065","article-title":"The growth and expansion of meningeal lymphatic networks are affected in craniosynostosis","volume":"149","author":"Ang","year":"2022","journal-title":"Development"},{"key":"ref_91","first-page":"413","article-title":"Calvarial and sutural re-development following craniectomy in the neonatal rabbit","volume":"129","author":"Mabbutt","year":"1979","journal-title":"J. Anat."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1097\/SCS.0b013e318258ba53","article-title":"Models of cranial suture biology","volume":"23","author":"Grova","year":"2012","journal-title":"J. Craniofacial Surg."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ajhg.2015.07.006","article-title":"A Genetic-Pathophysiological Framework for Craniosynostosis","volume":"97","author":"Twigg","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1242\/dev.076729","article-title":"Regulation of cranial morphogenesis and cell fate at the neural crest-mesoderm boundary by engrailed 1","volume":"139","author":"Deckelbaum","year":"2012","journal-title":"Development"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-0-387-46954-6_14","article-title":"Molecular bases of human neurocristopathies","volume":"589","author":"Etchevers","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuron.2008.06.025","article-title":"Coordinated actions of the forkhead protein Foxp1 and Hox proteins in the columnar organization of spinal motor neurons","volume":"59","author":"Rousso","year":"2008","journal-title":"Neuron"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ydbio.2016.09.019","article-title":"Cerebrovascular defects in Foxc1 mutants correlate with aberrant WNT and VEGF\u2014A pathways downstream of retinoic acid from the meninges","volume":"420","author":"Mishra","year":"2016","journal-title":"Dev. Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1749-8104-7-2","article-title":"Meningeal defects alter the tangential migration of cortical interneurons in Foxc1hith\/hith mice","volume":"7","author":"Zarbalis","year":"2012","journal-title":"Neural Dev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0012-1606(03)00355-5","article-title":"Progression of calvarial bone development requires Foxc1 regulation of Msx2 and Alx4","volume":"262","author":"Rice","year":"2003","journal-title":"Dev. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1523\/JNEUROSCI.4046-06.2007","article-title":"Zic1 and Zic3 regulate medial forebrain development through expansion of neuronal progenitors","volume":"27","author":"Inoue","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_101","first-page":"148","article-title":"Meningeal retinoic acid contributes to neocortical lamination and radial migration during mouse brain development","volume":"6","author":"Haushalter","year":"2017","journal-title":"Biol. Open"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"14973","DOI":"10.1523\/JNEUROSCI.1156-14.2014","article-title":"Migration of oligodendrocyte progenitor cells is controlled by transforming growth factor \u03b2 family proteins during corticogenesis","volume":"34","author":"Choe","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1523\/JNEUROSCI.22-14-06029.2002","article-title":"A critical function of the pial basement membrane in cortical histogenesis","volume":"22","author":"Halfter","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","article-title":"CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas","volume":"140","author":"Sievers","year":"2020","journal-title":"Acta Neuropathol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/ng.422","article-title":"FOXC1 is required for normal cerebellar development and is a major contributor to chromosome 6p25.3 Dandy-Walker malformation","volume":"41","author":"Aldinger","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpn.2009.01.005","article-title":"New trends in neuronal migration disorders","volume":"14","author":"Verrotti","year":"2010","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00006534-200202000-00035","article-title":"Dura mater biology: Autocrine and paracrine effects of fibroblast growth factor 2","volume":"109","author":"Spector","year":"2002","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nature01545","article-title":"The BMP antagonist noggin regulates cranial suture fusion","volume":"422","author":"Warren","year":"2003","journal-title":"Nature"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0070-2153(05)66009-7","article-title":"Cranial suture biology","volume":"66","author":"Lenton","year":"2005","journal-title":"Curr. Top. Dev. Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1083\/jcb.200209039","article-title":"Lineage-specific requirements of beta-catenin in neural crest development","volume":"159","author":"Hari","year":"2002","journal-title":"J. Cell Biol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.devcel.2011.04.010","article-title":"\u03b2-Catenin-dependent FGF signaling sustains cell survival in the anterior embryonic head by countering Smad4","volume":"20","author":"Paek","year":"2011","journal-title":"Dev. Cell"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1242\/dev.128.8.1253","article-title":"Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development","volume":"128","author":"Brault","year":"2001","journal-title":"Development"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e31018","DOI":"10.7554\/eLife.31018","article-title":"BMP and FGF signaling interact to pattern mesoderm by controlling basic helix-loop-helix transcription factor activity","volume":"7","author":"Row","year":"2018","journal-title":"eLife"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/bdrc.20013","article-title":"The neural crest: Basic biology and clinical relationships in the craniofacial and enteric nervous systems","volume":"72","author":"Farlie","year":"2004","journal-title":"Birth Defects Res. Part C Embryo Today Rev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000100354","article-title":"The neural crest: Understanding stem cell function in development and disease","volume":"4","author":"Fuchs","year":"2007","journal-title":"Neurodegener. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11910-009-0034-5","article-title":"Advances in meningioma therapy","volume":"9","author":"Norden","year":"2009","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ncl.2007.07.014","article-title":"Molecular pathogenesis of adult brain tumors and the role of stem cells","volume":"25","author":"Sauvageot","year":"2007","journal-title":"Neurol. Clin."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"21715","DOI":"10.1073\/pnas.1912858116","article-title":"Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors","volume":"116","author":"Patel","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations","volume":"45","author":"Brastianos","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","article-title":"Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution","volume":"171","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/2018.1.FOCUS17752","article-title":"Relationship between tumor location, size, and WHO grade in meningioma","volume":"44","author":"Magill","year":"2018","journal-title":"Neurosurg. Focus"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ccell.2018.11.009","article-title":"The Roles of Initiating Truncal Mutations in Human Cancers: The Order of Mutations and Tumor Cell Type Matters","volume":"35","author":"Levine","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_125","unstructured":"UCSF (2025, July 27). UCSF Meningioma Trial: Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas. Available online: https:\/\/clinicaltrials.ucsf.edu\/trial\/NCT02523014."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2017.168","article-title":"Advances in meningioma genetics: Novel therapeutic opportunities","volume":"14","author":"Preusser","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0046-8177(98)90246-5","article-title":"Analysis of cell cycle regulators: p16INK4A, pRb, and CDK4 in low- and high-grade meningiomas","volume":"29","author":"Tse","year":"1998","journal-title":"Hum. Pathol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","article-title":"Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas","volume":"159","author":"Wolter","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Mellai, M., Porrini Prandini, O., Mustaccia, A., Fogazzi, V., Allesina, M., Krengli, M., and Boldorini, R. (2021). Human TERT Promoter Mutations in Atypical and Anaplastic Meningiomas. Diagnostics, 11.","DOI":"10.3390\/diagnostics11091624"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.nec.2023.02.011","article-title":"Management of Atypical and Anaplastic Meningiomas","volume":"34","author":"Higgins","year":"2023","journal-title":"Neurosurg. Clin."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Collord, G., Tarpey, P., Kurbatova, N., Martincorena, I., Moran, S., Castro, M., Nagy, T., Bignell, G., Maura, F., and Young, M.D. (2018). An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-31659-0"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.18632\/oncotarget.27841","article-title":"Advances in meningioma genomics, proteomics, and epigenetics: Insights into biomarker identification and targeted therapies","volume":"11","author":"Nazem","year":"2020","journal-title":"Oncotarget"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13073-022-01051-9","article-title":"Single-cell profiling of human dura and meningioma reveals cellular meningeal landscape and insights into meningioma immune response","volume":"14","author":"Wang","year":"2022","journal-title":"Genome Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/neuonc\/noz061","article-title":"DNA methylation profiling to predict recurrence risk in meningioma: Development and validation of a nomogram to optimize clinical management","volume":"21","author":"Nassiri","year":"2019","journal-title":"Neuro-Oncology"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"200782","DOI":"10.1016\/j.omton.2024.200782","article-title":"Noncoding RNA landscape and their emerging roles as biomarkers and therapeutic targets in meningioma","volume":"32","author":"Joshi","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/brain\/awac342","article-title":"Inhibition of YAP\/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma","volume":"146","author":"Laraba","year":"2022","journal-title":"Brain"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jcp.25676","article-title":"The Emerging Role of TRAF7 in Tumor Development","volume":"232","author":"Zotti","year":"2017","journal-title":"J. Cell Physiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1158\/0008-5472.CAN-20-3669","article-title":"Loss-of-Function Mutations in TRAF7 and KLF4 Cooperatively Activate RAS-Like GTPase Signaling and Promote Meningioma Development","volume":"81","author":"Najm","year":"2021","journal-title":"Cancer Res."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Lynes, J., Flores-Milan, G., Rubino, S., Arrington, J., Macaulay, R., Liu, J.K.C., Beer-Furlan, A., Tran, N.D., Vogelbaum, M.A., and Etame, A.B. (2022). Molecular determinants of outcomes in meningiomas. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.962702"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41571-024-00966-z","article-title":"Synthetic lethal strategies for the development of cancer therapeutics","volume":"22","author":"Ngoi","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Qi, S.M., Dong, J., Xu, Z.Y., Cheng, X.D., Zhang, W.D., and Qin, J.J. (2021). PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.692574"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/16\/2694\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:30:44Z","timestamp":1760034644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/16\/2694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":141,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["cancers17162694"],"URL":"https:\/\/doi.org\/10.3390\/cancers17162694","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]}}}